Thursday, July 9, 2026

biotech · Solid Tumor Malignancies · FENC

FENNEC PHARMACEUTICALS

FENNEC PHARMACEUTICALS clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Research Triangle Park, USA HQ
1996 Founded
54 Employees
Public company Type
FENC · NYSE Ticker
Company details
Status
Public
HQ
Research Triangle Park, USA
Founded
1996
Employees
54
Programs
1
Drugs
1
Patents
8
Intelligence · Clinical Programs

FENNEC PHARMACEUTICALS projects

1 ClinicalTrials.gov programs sponsored by FENNEC PHARMACEUTICALS.

FENNEC PHARMACEUTICALS has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Pedmark® STS

    FENNEC PHARMACEUTICALS INC.

    Solid Tumor Malignancies

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does FENNEC PHARMACEUTICALS have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.